The Metabolic Syndrome and Inflammation

Sutherland, Julie P., McKinley, Benjamin, Eckel, Robert H.·2004·Metabolic Syndrome and Related Disorders
DOI 10.1089/met.2004.2.82

Cites (238)

Items 201–240 of 240

  1. Dietary regulation of fibrinolytic factors
    Margarete Mehrabian, J PETER, R BARNARD, Aldons Jake Lusis · 1990 · Atherosclerosis
  2. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets
    Osamah Hussein, Mira Rosenblat, Sorina Schlezinger, Shlomo Keidar, Aviram Michael · 1997 · British Journal of Clinical Pharmacology
  3. Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension
    Yasuaki Dohi, Masuo Ohashi, Masaya Sugiyama, Hiroyuki Takase, Koichi Sato, Ryuzo Ueda · 2003 · Hypertension Research
  4. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women
    B Janand-Delenne, Christophe Chagnaud, D. Raccah, Marie‐Christine Alessi, Irène Juhan-Vague, Philippe Vague · 1998 · International Journal of Obesity
  5. Time‐dependent effect of statins on platelet function in hypercholesterolaemia
    Luca Puccetti, A. L. Pasqui, Marcello Pastorelli, G. Bova, Michela Cercignani, Alberto Palazzuoli, P. Angori, A. Auteri, Fulvio Bruni · 2002 · European Journal of Clinical Investigation
  6. Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese Women
    Alenka Mavri, Mojca Stegnar, Michael Krebs, Jožica T. Sentočnik, Margarethe Geiger, B. R. Binder · 1999 · Arteriosclerosis Thrombosis and Vascular Biology
  7. Insulin Inhibits the Expression of Intercellular Adhesion Molecule-1 by Human Aortic Endothelial Cells through Stimulation of Nitric Oxide
    Ahmad Aljada · 2000 · The Journal of Clinical Endocrinology & Metabolism
  8. Higher Levels of Interleukin-6 Are Associated With Lower Echogenicity of Carotid Artery Plaques
    Hiroshi Yamagami, Kazuo Kitagawa, Yoji Nagai, Hidetaka Hougaku, Manabu Sakaguchi, Keisuke Kuwabara, Kimito Kondo, Tohru Masuyama, Masayasu Matsumoto, Masatsugu Hori · 2004 · Stroke
  9. Suppression of Nuclear Factor- B and Stimulation of Inhibitor B by Troglitazone: Evidence for an Anti-inflammatory Effect and a Potential Antiatherosclerotic Effect in the Obese
    Husam Ghanim · 2001 · The Journal of Clinical Endocrinology & Metabolism
  10. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
    J. B. McGill, David J. Schneider, Cynthia Lee Arfken · 1994 · Diabetes
  11. Postprandial hyperlipidemia: another correlate of the “hypertriglyceridemic waist” phenotype in men
    P Blackburn · 2003 · Atherosclerosis
  12. The extrinsic fibrinolytic system in survivors of myocardial infarction
    Torbjörn Nilsson, Owe Johnson · 1987 · Thrombosis Research
  13. Plasminogen Activator Inhibitor–1, Tissue-Type Plasminogen Activator, and Fibrinogen
    Ole Lander Svendsen, Christian Hassager, Claus Christiansen, Jørn Dalsgaard Nielsen, Kaj Winther · 1996 · Arteriosclerosis Thrombosis and Vascular Biology
  14. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice
    J. Ventre, Thomas W. Doebber, M. Wu, K. MacNaul, K. Stevens, M. Pasparakis, George A. Kollias, David E. Moller · 1997 · Diabetes
  15. The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
    G. Schonfeld · 1994 · Atherosclerosis
  16. Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must
    Laurence Piéroni, Jean‐Philippe Bastard, Annie Piton, L Khalil, Bernard Hainque, Claude Jardel · 2003 · Diabetes & Metabolism
  17. Pathophysiology of impaired pulsatile insulin release
    Peter Bergsten · 2000 · Diabetes/Metabolism Research and Reviews
  18. Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes
    Kohzo Takebayashi, Yoshimasa Aso, Toshihiko Inukai · 2004 · Metabolism
  19. Elevation of Serum C-Reactive Protein Levels Is Associated with Obesity in Boys
    Makoto Hiura, Toru Kikuchi, Keisuke Nagasaki, Makoto Uchiyama · 2003 · Hypertension Research
  20. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones
    Anne Leugers, Jens Lohrmann, Sandra Ernst, Burton E. Sobel, Christoph Bode, Thomas K. Nordt, Andreas Zirlik · 2004 · Thrombosis and Haemostasis
  21. Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension
    Kwang Kon Koh, Seung Hwan Han, Wook‐Jin Chung, Jeong Yeal Ahn, Dong‐Kyu Jin, Hyung Sik Kim, Gi Soo Park, Woong Chol Kang, Tae Hoon Ahn, Eak Kyun Shin · 2004 · The American Journal of Cardiology
  22. Relationship between Visceral Fat and PAI-1 in Overweight Men and Women before and after Weight Loss
    Maaike Kockx, Renée C. A. Leenen, Jacob C. Seidell, H. M. G. Princen, T. Kooistra · 1999 · Thrombosis and Haemostasis
  23. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes
    Greg A. Knock, Santosh Kumar Mishra, Philip Irving Aaronson · 1999 · European Journal of Pharmacology
  24. Hypertriglyceridemia and risk of coronary heart disease
    John E. Hokanson · 2002 · Current Cardiology Reports
  25. Evidence for a Direct Vascular Effect
    Thomas A. Buchanan, W P Meehan, Young Y. Jeng, Dong Gyu Yang, Timothy M. Chan, Jerry L. Nadler, Steven D. Scott, Robert K. Rude, Willa A. Hsueh · 1995
  26. Pioglitazone attenuates diet-induced hypertension in rats
    Laryssa N. Kaufman, Mary May Peterson, Lauren M. DeGrange · 1995 · Metabolism
  27. Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen Levels
    Evagelos Rizos, Angeliki Kostoula, Moses Elisaf, Dimitri P. Mikhailidis · 2002 · Angiology
  28. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle
    Kimika Eto, Yusuke Ohya, Yoshito Nakamura, Isao Abe, Masatoshi Fujishima · 2001 · European Journal of Pharmacology
  29. Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study)
    Winfried März, Karl Winkler, Markus Nauck, Bernhard Otto Böhm, Bernhard Rudolf Winkelmann · 2003 · The American Journal of Cardiology
  30. The patient with diabetes mellitus and heart failure: at-risk issues
    Thomas D. Giles · 2003 · The American Journal of Medicine
  31. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen.
    Masaoki Takano, Norio Itoh, Katsutoshi Yayama, M Yamano, Remiko Ohtani, H Okamoto · 1993 · PubMed
  32. Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease
    Wright B. Lauten, Qamar A Khan, Sanjay Rajagopalan, Stamatios Lerakis, Syed T. Rahman, Sampath Parthasarathy, Bobby V. Khan · 2003 · The American Journal of Cardiology
  33. Lack of Evidence for Secretion of Plasminogen Activator Inhibitor-1 by Human Subcutaneous Adipose Tissue in Vivo
    John S Yudkin, Simon W. Coppack, Karen Bulmer, Ataullah Rawesh, Vidya Mohamed‐Ali · 1999 · Thrombosis Research
  34. The Effect of Insulin Treatment on the Balance between Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients
    Thomas Vukovich, Sylvia Proidl, Paul Knöbl, Harald Teufelsbauer, Christoph Schnack, Guntram Schernthaner · 1992 · Thrombosis and Haemostasis
  35. Impaired Fibrinolysis in Hypertension and Obesity Due to High Plasminogen Activator Inhibitor-1 Level in Plasma.
    Tetsumei Urano, Yumi Kojima, Masaaki Takahashi, K. Serizawa, Kenji Sakakibara, Yumiko Takada, Akikazu Takada · 1993 · The Japanese Journal of Physiology
  36. Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premonopausal women with central obesity
    Giovanni De Pergola, V. De Mitrio, A. Perricci, Mauro Cignarelli, Gabriella Garruti, S. Lomuscio, G. M. Ferri, Oronzo Schiraldi, RICCARDO GIORGINO · 1992 · Metabolism
  37. Fibrinolysis in insulin dependent diabetic patients with or without nephropathy
    Rehab Mahmoud, D. Raccah, Marie‐Christine Alessi, M.F. Aillaud, Irène Juhan-Vague, P Vague · 1992 · Fibrinolysis and Proteolysis
  38. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
    Jean‐Philippe Bastard, Éric Bruckert, Jean‐Jacques Robert, Annick Ankri, André Grimaldi, Claude Jardel, Bernard Hainque · 1995 · PubMed
  39. Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare
    Takeyuki Nakamura, Hisashi Adachi, Yuji Hirai, Akira Satoh, Masanao Ohuchida, Tsutomu Imaizumi · 2003 · Metabolism
  40. Untitled work
    Alberti · 1998 · 10.1002/(sici)1096-9136(199807)15:7